Curi Wealth Management, LLC G1 Therapeutics, Inc. Transaction History

Curi Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$1.12 - $3.73 $59 - $197	53 Added 0.07%	70,795 $215,000
Q3 2023 Nov 06, 2023	BUY	$1.22 - $2.67 $13,054 - $28,569	10,700 Added 17.82%	70,742 $101,000
Q2 2023 Jul 31, 2023	SELL	$2.46 - $3.14 $51,660 - $65,940	-21,000 Reduced 25.91%	60,042 $149,000
Q1 2023 May 03, 2023	BUY	$2.57 - $8.16 $84 - $269	33 Added 0.04%	81,042 $217,000
Q4 2022 Feb 03, 2023	BUY	$5.19 - $13.5 $115,591 - $300,672	22,272 Added 37.92%	81,009 $439,000
Q3 2022 Nov 08, 2022	SELL	$5.17 - $16.99 $134,420 - $441,739	-26,000 Reduced 30.68%	58,737 $734,000
Q2 2022 Aug 08, 2022	BUY	$4.04 - $8.51 $342,337 - $721,111	84,737 New	84,737 $419,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.